Ketamine therapy for hard-to-treat depression
Treatments studied
Part of Mental health, Pain clinical trials.
This study tests whether ketamine, given with talk therapy, can help people whose depression hasn't improved with at least two antidepressants. It aims to see if this combination can reduce depression symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You can speak, read, and understand English.
- You are generally in good health.
- You have been diagnosed with depression that hasn't improved after trying at least two different antidepressants in the past two years.
- You do not have certain heart, lung, or other health conditions that could make ketamine unsafe.
- You are not taking medications that could interact with ketamine, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if ketamine combined with talk therapy helps people with both chronic pain and PTSD. Participants receive ketamine through an IV in group therapy sessions over several weeks, with the goal of reducing pain and PTSD symptoms.
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
This study tests how a single dose of ketamine affects certain brain and body markers in people with severe depression. It aims to find better ways to predict who will respond to ketamine, which may help personalize depression treatment in the future.
This trial tests if ketamine can help people with long-term health issues. It aims to find new treatments for chronic conditions that haven't responded well to other therapies.
This trial compares two forms of ketamine—given by IV or as a nasal spray—in people with major depression that hasn't improved after trying at least two other antidepressants. The goal is to see which treatment works better.
This study combines behavioral activation therapy (a type of counseling that helps you re-engage in positive activities) with ketamine infusions to treat depression that hasn't improved with standard antidepressants. The goal is to see if adding this therapy makes ketamine work better and last longer.
Hear when a new Chronic pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.